Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji Kumar, Philippe Moreau, Cristina Gasparetto et al.|The Lancet Oncology|2020Cited by 401
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureMohammed Wattad, Daniela Weber, Konstanze Döhner et al.|Leukemia|2017Cited by 118
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use programKai Hübel, Nicolaus Kröger, Maximilian M. Fresen et al.|Bone Marrow Transplantation|2010Cited by 79